This compound is a pharmaceutical intermediate used in the synthesis of active pharmaceutical ingredients. It features a boron-containing heterocyclic structure, making it suitable for cross-coupling reactions in medicinal chemistry.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 286961-14-6
1-Carbobenzoxy-1,2,3,6-tetrahydro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Pharmaceutical intermediate for drug synthesis
(S)-1-N-Cbz-Pipecolinic acid
Pharmaceutical intermediate for peptide synthesis
(2R)-1-[(tert-butoxy)carbonyl]piperidine-2-carboxylic acid
Pharmaceutical intermediate for peptide synthesis
N-nitroso-desmethyl-minocycline-1
nitrosamine impurity reference standard
1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydropyridin-1(2H)-yl)ethan-1-one
Boronic ester protecting group reagent
1-Methyl-1,2,3,6-tetrahydropyridine-4-boronic acid, pinacol ester
boronic ester research reagent
4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(2,2,2-TRIFLUOROETHYL)-1,2,3,6-TETRAHYDROPYRIDINE
boronic ester pharmaceutical intermediate
tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine-1-carboxylate
VVDCRJGWILREQH-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CCN(CC2)C(=O)OC(C)(C)C